Finance

Lists
688289:SHA
Sansure Biotech Inc
CN¥16.21
-0.86%
(-0.14) 1D
Oct 14, 11:20:30 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688289...
Open
CN¥16.35
High
CN¥16.39
Low
CN¥16.12
Mkt. cap
9.56B
Avg. vol.
5.16M
Volume
1.38M
Dividend
3.24%
Quarterly dividend
CN¥0.13
Ex-dividend date
Jun 22, 2026
P/E ratio
69.83
52-wk high
CN¥22.94
52-wk low
CN¥13.40
EPS
CN¥0.23
No. of employees
2K
Open
CN¥16.35
High
CN¥16.39
Low
CN¥16.12
Mkt. cap
9.56B
Avg. vol.
5.16M
Volume
1.38M
Dividend
3.24%
Quarterly dividend
CN¥0.13
Ex-dividend date
Jun 22, 2026
P/E ratio
69.83
52-wk high
CN¥22.94
52-wk low
CN¥13.40
EPS
CN¥0.23
No. of employees
2K
News stories
From web sources and news partners
About Sansure Biotech Inc
CEO-
Employees2.06K
FoundedApr 23, 2008
Headquarters-
SectorMedical device
Websitesansure.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
375.52M
397.39M
437.35M
396.97M
Cost of goods sold
112.00M
84.01M
116.71M
126.95M
Cost of revenue
112.00M
84.01M
116.71M
126.95M
Research and development expenses
60.42M
47.60M
56.53M
62.58M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
212.04M
230.48M
205.78M
210.73M
Operating expense
246.86M
325.42M
267.76M
282.41M
Total operating expenses
358.85M
409.43M
384.47M
409.36M
Operating income
16.66M
-12.04M
52.88M
-12.39M
Other non operating income
1.83M
-2.67M
-2.65M
2.04M
EBT including unusual items
9.17M
-4.69M
51.12M
44.78M
EBT excluding unusual items
31.64M
2.53M
60.58M
-5.02M
Income tax expense
-10.07M
3.36M
9.32M
5.26M
Effective tax rate
-109.87%
-71.66%
18.24%
11.75%
Other operating expenses
-12.07M
15.56M
-1.69M
6.29M
Net income
28.60M
7.62M
49.74M
48.28M
Net profit margin
7.62%
1.92%
11.37%
12.16%
Earnings per share
-
-
-
-
Interest and investment income
20.30M
21.24M
16.95M
19.32M
Interest expense
-6.35M
-5.72M
-6.59M
-7.24M
Net interest expenses
13.94M
15.52M
10.35M
12.09M
Depreciation and amortization charges
-
-
-
-
EBITDA
51.82M
38.37M
103.28M
45.50M
Gain or loss from assets sale
-3.04M
2.95M
-
11.43M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps